Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa

American Journal of Hematology

Volumn 87, Issue 6, 2012, Pages 573-578

  Mbulaiteye, Sam M ^a   Anderson, William F ^a   Ferlay, Jacques ^b   Bhatia, Kishor ^a   Chang, Cindy ^a   Rosenberg, Philip S ^a   Devesa, Susan S ^a   Parkin, Donald M ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CHILD; DISEASE COURSE; FEMALE; GEOGRAPHY; GERIATRICS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AMERICAS; ASIA; AUSTRALIA; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84861348082     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23187     Document Type: Article

References (38)

1. Leoncini L, Raphael M, Stein H, et al., editors. Burkitt Lymphoma. Lyon: International Agency for Research on Cancer (IARC); 2008. pp 262-264.
2. Klein G. Burkitt lymphoma-A stalking horse for cancer research? Semin Cancer Biol 2009; 19: 347-350.
3. Leucci E, Cocco M, Onnis A, et al. MYC translocation-negative classical Burkitt lymphoma cases: An alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 2008; 216: 440-450.
4. Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419-2430.
5. Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006; 354: 2431-2442.
6. Mbulaiteye SM, Anderson WF, Bhatia K, et al. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer 2010; 126: 1732-1739.
7. Mbulaiteye SM, Biggar RJ, Bhatia K, et al. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer 2009; 53: 366-370.
8. Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 2008; 123: 2658-2663.
9. Guech-Ongey M, Simard EP, Anderson WF, et al. AIDS-related Burkitt lymphoma in the United States: What do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood 2010; 116: 5600-5604.
10. Smith SM. AIDS-related BL and CD4 count: A clue? Blood 2010; 116: 5435-5436.
11. Macmahon B. Epidemiological evidence of the nature of Hodgkin's disease. Cancer 1957; 10: 1045-1054.
12. Jarrett RF. Viruses and Hodgkin's lymphoma. Ann Oncol 2002; 13: 23-29.
13. Klapper W, Szczepanowski M, Burkhardt B, et al. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 2008; 112: 1374-1381.
14. Ferlay J, Parkin DM, Curado MP, et al. Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9. Lyon, France: International Agency for Research on Cancer; 2010.
15. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Geneva: World Health Organization; 1977.
16. International Statistical Classification of Diseases and Related Health Problem, Tenth Revision. Geneva: World Health Organization; 1992.
17. Manual of Tumor Nomenclature. New York: American Cancer Society; 1951.
18. International Classification of Diseases for Oncology. Geneva: World Health Organization; 1976.
19. International Classification of Diseases for Oncology. Geneva: World Health Organization; 1990.
20. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin LH, Parkin DM, Whelan S, editors. International Classification of Diseases for Oncology (ICD-O-3). Geneva (Switzerland): World Health Organization; 2000.
21. Doll R, Payne P, Waterhouse JAH, editors. Cancer Incidence in Five Continents. Geneva: Union Internationale Contre le Cancer; 1966.
22. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol 1995; 141: 300-304.
23. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
24. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991; 12: 425-457.
25. Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983; 39: 311-324.
26. Rosenberg PS, Anderson WF. Proportional hazards models and age-period-cohort analysis of cancer rates. Stat Med 2010; 29: 1228-1238.
27. Tarone RE, Chu KC. Evaluation of birth cohort patterns in population disease rates. Am J Epidemiol 1996; 143: 85-91.
28. AIDS Epidemic Update: November 2009. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO); 2009.
29. Ries LAG, Devesa SS. Cancer incidence, mortality, and patient survival in the United States. In: Schottenfeld D, Fraumeni JF, Jr, editors. Cancer Epidemiology and Prevention. New York: Oxford University Press; 2006. pp 139-167.
30. Perkins AS, Friedberg JW. Burkitt lymphoma in adults. Hematology Am Soc Hematol Educ Program 2008; 2008: 341-348.
31. Thomas DA, Faderl S, O'Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 2006; 106: 1569-1580.
32. Kelly JL, Toothaker SR, Ciminello L, et al. Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens. Clin Lymphoma Myeloma 2009; 9: 307-310.
33. Mbulaiteye SM, Parkin DM, Rabkin CS. Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am 2003; 17: 673-696, v.
34. Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer 2006; 6: 603-612.
35. Naresh KN, Ibrahim HA, Lazzi S, et al. Diagnosis of Burkitt lymphoma using an algorithmic approach-applicable in both resource-poor and resource-rich countries. Br J Haematol, 2011; doi:10.1111/j.1365-2141.2011.08771.x (Epub ahead of print).
36. Wright DH. What is Burkitt's lymphoma and when is it endemic? Blood 1999; 93: 758.
37. Haralambieva E, Boerma EJ, van Imhoff GW, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 2005; 29: 1086-1094.
38. Harris NL, Jaffe ES, Diebold J, et al. Lymphoma classification-From controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol 2000; 11: 3-10.